Spontaneous multidrug transport in human glioma cells is regulated by transforming growth factors type beta
- PMID: 1679277
- DOI: 10.1007/BF00296374
Spontaneous multidrug transport in human glioma cells is regulated by transforming growth factors type beta
Abstract
The multidrug transporting cell membrane molecule P-glycoprotein can be spontaneously expressed in human glioma cells. Transcripts of mdr genes were detected in glial tumor cells by polymerase chain reaction and Northern blotting, expression of P-glycoprotein was analyzed by immunocytochemistry and functional activity by cytofluorometry of fluorescent probe transport. In vitro treatment of glioma cells with vincristine induced coordinate over-expression of both mdr1 and mdr3 genes associated with very high P-glycoprotein-mediated multidrug transport, resistant to the inhibitory activity of chemosensitizers like verapamil. The physiological modulators of multidrug transport are as yet unknown. We therefore initiated a screening program to analyze the effects of cytokines on multidrug transport. We observed, that transforming growth factors (TGF)-beta 1, -beta 2, and -beta 1.2-but not the related bone morphogenetic protein (BMP) 2--inhibited multidrug transport. Interestingly, BMP 2 antagonized the TGF-beta induced inhibition of multidrug transport.
Similar articles
-
Multidrug transport in human glioblastoma cells is inhibited by transforming growth factors type beta 1, beta 2, and beta 1.2.J Neurosci Res. 1991 Feb;28(2):310-4. doi: 10.1002/jnr.490280218. J Neurosci Res. 1991. PMID: 2033654
-
Transforming growth factors type beta inhibit multidrug transport in rat astrocyte cell lines.Autoimmunity. 1991;9(3):269-75. doi: 10.3109/08916939109007653. Autoimmunity. 1991. PMID: 1685677
-
Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo.Acta Neuropathol. 2000 May;99(5):555-62. doi: 10.1007/s004010051160. Acta Neuropathol. 2000. PMID: 10805101
-
P-glycoprotein: multidrug-resistance and a superfamily of membrane-associated transport proteins.FASEB J. 1989 Dec;3(14):2583-92. doi: 10.1096/fasebj.3.14.2574119. FASEB J. 1989. PMID: 2574119 Review.
-
Molecular analysis of the multidrug transporter.Cytotechnology. 1993;12(1-3):33-62. doi: 10.1007/BF00744657. Cytotechnology. 1993. PMID: 7765331 Review.
Cited by
-
The multidrug-resistance gene MDR1 is expressed in human glial tumors.Acta Neuropathol. 1991;82(6):516-9. doi: 10.1007/BF00293387. Acta Neuropathol. 1991. PMID: 1723831
-
Therapeutic implications of the TGF-beta system.J Mammary Gland Biol Neoplasia. 1996 Oct;1(4):391-7. doi: 10.1007/BF02017395. J Mammary Gland Biol Neoplasia. 1996. PMID: 10887513 Review.
-
Detection of two transforming growth factor-beta-related morphogens, bone morphogenetic proteins-4 and -5, in RNA of multiple sclerosis and Creutzfeldt-Jakob disease lesions.Acta Neuropathol. 1995;90(1):76-9. doi: 10.1007/BF00294462. Acta Neuropathol. 1995. PMID: 7572083
-
ABCB1 and ABCC1 Function during TGF-β-Induced Epithelial-Mesenchymal Transition: Relationship between Multidrug Resistance and Tumor Progression.Int J Mol Sci. 2023 Mar 23;24(7):6046. doi: 10.3390/ijms24076046. Int J Mol Sci. 2023. PMID: 37047018 Free PMC article.
-
Intercrines in brain pathology. Expression of intercrines in a multiple sclerosis and Morbus Creutzfeldt-Jakob lesion.Acta Neuropathol. 1993;86(4):393-6. doi: 10.1007/BF00369453. Acta Neuropathol. 1993. PMID: 7504862
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical